← FDA Drug Approvals (Drugs@FDA)

SITAGLIPTIN PHOSPHATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN PHARMS INC · Approved 2012-10-10

Drug application

FDA Application #

ANDA202473

Application type

Abbreviated New Drug Application (Generic)

Brand name

SITAGLIPTIN PHOSPHATE

Generic name

Sitagliptin Phosphate

Active ingredients

SITAGLIPTIN PHOSPHATE

Dosage form

TABLET

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

MYLAN PHARMS INC

First approval

2012-10-10

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown